Harry Björkbacka
71 – 80 of 114
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Apolipoprotein B100 autoimmunity and atherosclerosis - disease mechanisms and therapeutic potential.
(
- Contribution to journal › Article
-
Mark
Total and differential leucocyte counts in relation to incidence of stroke subtypes and mortality: a prospective cohort study
(
- Contribution to journal › Article
-
Mark
Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL
(
- Contribution to journal › Article
-
Mark
Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmö Diet and Cancer Study.
(
- Contribution to journal › Article
-
Mark
Evidence Supporting a Key Role of Lp-PLA2-Generated Lysophosphatidylcholine in Human Atherosclerotic Plaque Inflammation.
(
- Contribution to journal › Article
-
Mark
Atherosclerosis: cell biology and lipoproteins.
(
- Contribution to journal › Article
-
Mark
Mobilization of regulatory T cells in response to carotid injury does not influence subsequent neointima formation.
(
- Contribution to journal › Article
-
Mark
Soluble Urokinase Plasminogen Activator Receptor is Associated With Inflammation in the Vulnerable Human Atherosclerotic Plaque.
(
- Contribution to journal › Article
- 2011
-
Mark
Immunization with cationized BSA inhibits progression of disease in ApoBec-1/LDL receptor deficient mice with manifest atherosclerosis.
(
- Contribution to journal › Article
-
Mark
Genome-Wide Expression Profiling and Mutagenesis Studies Reveal that Lipopolysaccharide Responsiveness Appears To Be Absolutely Dependent on TLR4 and MD-2 Expression and Is Dependent upon Intermolecular Ionic Interactions
(
- Contribution to journal › Article